Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Goldschmidt

Showing results (281-290 of 472) with videos related to

Pageof 48
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2005
Long-term survival after surgical intervention for bone disease in multiple myelomaF Zeifang, A Zahlten-Hinguranage, H Goldschmidt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 14, 1999
Ceftazidime in combination with glycopeptide antibiotic is an effective first-line therapy for patients undergoing high-dose therapy with autologous peripheral blood stem cell supportG Egerer, H Goldschmidt, N Streich, et al.
The British Journal of Dermatology|February 1, 1997
Dominantly inherited epidermal acantholysis in dogs, simulating human benign familial chronic pemphigus (Hailey-Hailey disease)H Sueki, K Shanley, M H Goldschmidt, et al.
American Journal of Hematology|April 17, 1998
Decreased numbers of circulating B cells in myeloma patients with reduction after conventional chemotherapyC Kallmeyer, M Wallmeier, K Kiel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1997
High-dose therapy with peripheral blood progenitor cell transplantation in multiple myelomaH Goldschmidt, U Hegenbart, M Wallmeier, et al.
Stem Cells (Dayton, Ohio)|December 1, 1995
Sequential high-dose treatment with peripheral blood progenitor cell transplantation in patients with multiple myelomaH Goldschmidt, U Hegenbart, M Moos, et al.
Molecular Carcinogenesis|October 1, 1996
Perturbation in connexin 43 and connexin 26 gap-junction expression in mouse skin hyperplasia and neoplasiaM J Sawey, M H Goldschmidt, B Risek, et al.
Journal of Autoimmunity|February 27, 2001
Altered self-reactive antibody repertoires are a general feature of patients with myelodysplastic syndromeD Stahl, G Egerer, H Goldschmidt, et al.
Deutsche Medizinische Wochenschrift (1946)|April 25, 1997
[Ambulatory therapy of multiple myeloma with vincristine, adriamycin and dexamethasone]G Egerer, U Hegenbart, H Salwender, et al.
Leukemia|December 1, 1996
Myeloablative therapy with blood stem cell transplantation is effective in mantle cell lymphomaR Haas, G Brittinger, P Meusers, et al.
Pageof 48

Showing results (281-290 of 472) with videos related to

Sort By:
Pageof 48
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2005
Long-term survival after surgical intervention for bone disease in multiple myelomaF Zeifang, A Zahlten-Hinguranage, H Goldschmidt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 14, 1999
Ceftazidime in combination with glycopeptide antibiotic is an effective first-line therapy for patients undergoing high-dose therapy with autologous peripheral blood stem cell supportG Egerer, H Goldschmidt, N Streich, et al.
The British Journal of Dermatology|February 1, 1997
Dominantly inherited epidermal acantholysis in dogs, simulating human benign familial chronic pemphigus (Hailey-Hailey disease)H Sueki, K Shanley, M H Goldschmidt, et al.
American Journal of Hematology|April 17, 1998
Decreased numbers of circulating B cells in myeloma patients with reduction after conventional chemotherapyC Kallmeyer, M Wallmeier, K Kiel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1997
High-dose therapy with peripheral blood progenitor cell transplantation in multiple myelomaH Goldschmidt, U Hegenbart, M Wallmeier, et al.
Stem Cells (Dayton, Ohio)|December 1, 1995
Sequential high-dose treatment with peripheral blood progenitor cell transplantation in patients with multiple myelomaH Goldschmidt, U Hegenbart, M Moos, et al.
Molecular Carcinogenesis|October 1, 1996
Perturbation in connexin 43 and connexin 26 gap-junction expression in mouse skin hyperplasia and neoplasiaM J Sawey, M H Goldschmidt, B Risek, et al.
Journal of Autoimmunity|February 27, 2001
Altered self-reactive antibody repertoires are a general feature of patients with myelodysplastic syndromeD Stahl, G Egerer, H Goldschmidt, et al.
Deutsche Medizinische Wochenschrift (1946)|April 25, 1997
[Ambulatory therapy of multiple myeloma with vincristine, adriamycin and dexamethasone]G Egerer, U Hegenbart, H Salwender, et al.
Leukemia|December 1, 1996
Myeloablative therapy with blood stem cell transplantation is effective in mantle cell lymphomaR Haas, G Brittinger, P Meusers, et al.
Pageof 48